Akèy › Lupus › Texas

Etid klinik pou Lupus nan Texas

26 etid pou Lupus ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Research Site, El Paso
Research Site, Houston

Ap rekriteFaz 3

Laj 5 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT05835310

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Amarillo Medical Specialists Rheumatology, Amarillo
Amarillo Center for Clinical Research, Amarillo
Arthritis and Rheumatology Research Institute, Frisco
ak 5 plis

Ap rekriteFaz 3

Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07438496

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Epic Medical Research /ID# 279180, Red Oak

Ap rekriteFaz 1

Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07607964

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Research Site, Austin
Research Site, Baytown
Research Site, Colleyville
ak 3 plis

Ap rekriteFaz 3

Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT07430306

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
ak 2 plis

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Research Site, Allen
Research Site, Mesquite

Ap rekriteFaz 1

Laj 18 a 65 · Tout sèks · Mizajou Sep 18, 2026 · NCT07201558

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Amarillo Center for Clinical Research, Amarillo
Precision Comprehensive Clinical Research Solutions - Colleyville, Colleyville
Precision Comprehensive Clinical Research Solutions, Euless
ak 4 plis

Ap rekriteFaz 2

Laj 18 a 74 · Tout sèks · Mizajou Sep 17, 2026 · NCT07409181

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Baylor College of Medicine, Houston

Ap rekriteFaz 1

Laj 18 a 60 · Tout sèks · Mizajou Sep 14, 2026 · NCT06975787

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

North Texas Center for Clinical Research, Frisco
Accurate Clinical Research, Humble

Ap rekriteFaz 3

Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07355218

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

The University of Texas Southwestern Medical Center, Dallas

Ap rekriteFaz 2

Laj 12 a 70 · Tout sèks · Mizajou Sep 14, 2026 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Allen Arthritis, Allen
Arthritis and Rheumatology Research Institute PLLC, Allen
Arthritis Care of Texas, Corpus Christi

Ap rekriteFaz 3

Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07332481

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sl0044 50738, Bellaire
Sl0044 50781, El Paso
Sl0044 50673, Fort Worth
ak 7 plis

Ap rekriteFaz 3

Laj 16 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06617325

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Arthritis Care of Texas - Corpus Christi, Corpus Christi
Lone Star Arthritis & Rheumatology Associates, P.C., Denton
El Paso Medical Research Institute (MedResearch, Inc), El Paso
ak 1 plis

Ap rekriteEtid obsèvasyon

Laj 16 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07175285

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of Texas MD Anderson Cancer Center, Houston

Ap rekriteFaz 1/2

Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Texas Transplant Institute, San Antonio

Ap rekriteFaz 2

Laj 12 a 65 · Tout sèks · Mizajou Aug 24, 2026 · NCT07053800

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Integrative Rheumatology of South Texas - Harlingen /ID# 276458, Harlingen

Ap rekriteFaz 1

Laj 18 a 75 · Tout sèks · Mizajou Aug 10, 2026 · NCT06977724

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Prolato Clinical Research Center, Houston

Ap rekriteFaz 2

Laj 18 a 100 · Tout sèks · Mizajou Jul 30, 2026 · NCT05268289

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Rheumatology Care Center, PLLC, Bellaire
Texas Arthritis Center, El Paso
Novel Research, LLC., Houston
ak 3 plis

Ap rekriteFaz 3

Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07201129

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Investigative Site, Allen
Investigative Site, Arlington
Investigative Site, Colleyville

Ap rekriteFaz 2

Laj 18 a 80 · Tout sèks · Mizajou Jul 27, 2026 · NCT07260877

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Accurate Clinical Research, League City
Epic Medical Research, Red Oak

Ap rekriteFaz 3

Laj 12 a 100 · Tout sèks · Mizajou Jul 8, 2026 · NCT06133972

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Stryde Research, Plano
Tranquil Clinical Research, Webster

Ap rekriteFaz 1

Laj 18 a 70 · Tout sèks · Mizajou Jun 5, 2026 · NCT06613360

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

US04-0, Irving
US02-0, San Antonio

Ap rekriteFaz 1/2Volontè an sante akeyi

Laj 18 a 70 · Tout sèks · Mizajou Jun 2, 2026 · NCT06625671

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT04751396

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

MD Anderson Cancer Center, Houston
The University of Texas Health Science Center at Houston, Houston

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT06434363

Lupus Landmark Study: A Prospective Registry and Biorepository

UT Southwestern Medical Center, Dallas

Ap rekriteEtid obsèvasyon

Laj 18 a 110 · Tout sèks · Mizajou Apr 15, 2026 · NCT05934149

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Climb Bio Investigative Site #100104, Allen
Climb Bio Investigative Site #100101, San Antonio

Ap rekriteFaz 1

Laj 18 a 65 · Tout sèks · Mizajou Mar 27, 2026 · NCT07011043

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.